summary
Introduced
10/25/2017
10/25/2017
In Committee
10/25/2017
10/25/2017
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
Medicare Drug Price Negotiation Act
AI Summary
This bill, the Medicare Drug Price Negotiation Act, would require the Secretary of Health and Human Services to negotiate lower drug prices for Medicare Part D drugs. The Secretary would identify a set of high-cost or high-utilization drugs for negotiation each year, and if negotiations fail, a fallback price would apply based on the lowest price from certain other government programs. The bill would also require the Secretary to establish a formulary for Medicare Part D plans or mandate changes to plan formularies to take into account the negotiated prices. Additionally, the bill would require drug manufacturers to provide rebates for drugs dispensed to low-income Medicare beneficiaries.
Committee Categories
Budget and Finance
Sponsors (8)
Bernie Sanders (I)*,
Richard Blumenthal (D),
Al Franken (D),
Kirsten Gillibrand (D),
Kamala Harris (D),
Patrick Leahy (D),
Jack Reed (D),
Elizabeth Warren (D),
Last Action
Read twice and referred to the Committee on Finance. (on 10/25/2017)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://www.congress.gov/bill/115th-congress/senate-bill/2011/all-info |
BillText | https://www.congress.gov/115/bills/s2011/BILLS-115s2011is.pdf |
Bill | https://www.congress.gov/115/bills/s2011/BILLS-115s2011is.pdf.pdf |
Loading...